DLTR
40
-2
C
62
-3
NAVI
52
-3
DNB
82
-2
PLD
56
-5
PSX
50
3
V
72
-4
CMS
64
4
SPG
63
7
CME
64
5
PNW
70
3
HST
59
7
AES
41
-2
UHS
62
6
PPL
59
5
AMGN
31
-16
GME
70
2
MOS
43
-5
HUM
41
-2
PFG
50
-2
DLTR
40
-2
C
62
-3
NAVI
52
-3
DNB
82
-2
PLD
56
-5
PSX
50
3
V
72
-4
CMS
64
4
SPG
63
7
CME
64
5
PNW
70
3
HST
59
7
AES
41
-2
UHS
62
6
PPL
59
5
AMGN
31
-16
GME
70
2
MOS
43
-5
HUM
41
-2
PFG
50
-2
Financhill
Back

Purple Innovation Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
47

PRPL
Purple Innovation

Last Price:
0.96
Seasonality Move:
17.22%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
137.02
Seasonality Move:
14.88%
Sell
47
Purple Innovation (PRPL) is a Sell

Is Purple Innovation a Buy, Sell or Hold?

  • The current Purple Innovation [PRPL] share price is $0.92. The Score for PRPL is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • PRPL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRPL Stock Price Chart

What is Purple Innovation's stock price today?

  • The Purple Innovation share price today is $0.92
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRPL is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

PRPL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 54.78 Buy
Chaikin Money Flow: -91781 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.83 - 0.91) Buy
Bollinger Bands (100): (0.88 - 1.22) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

PRPL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.86 Buy
20-day SMA: 0.87 Buy
50-day SMA: 0.92 Buy
200-day SMA: 1.26 Sell
8-day EMA: 0.88 Buy
20-day EMA: 0.88 Buy
50-day EMA: 0.93 Sell
200-day EMA: 1.22 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Purple Innovation Earnings Growth & PRPL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and an increase next year of $0.17 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Purple Innovation Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):